✦ LIBER ✦

Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver-transplanted for Hepatitis B Virus-related Cirrhosis at Low Risk of Hepatitis B Virus Recurrence

✍ Scribed by I Lenci; G Tisone; D DiPaolo; Ajay K Duseja

Book ID: 117689761
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 145 KB
Volume: 1
Category: Article
ISSN: 0973-6883
DOI: 10.1016/s0973-6883(11)60134-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of complete and sustained prophyl

Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence

✍ Ilaria Lenci; Giuseppe Tisone; Daniele Di Paolo; Fabio Marcuccilli; Laura Tarici 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 708 KB

Assessment of the FecalLactobacilliPopul

Assessment of the FecalLactobacilliPopulation in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis and Hepatitis B Cirrhosis Treated with Liver Transplant

✍ Wu, Zhong-Wen; Lu, Hai-Feng; Wu, Jianping; Zuo, Jian; Chen, Ping; Sheng, Ji-Fang 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 288 KB

Prophylaxis against hepatitis B virus re

Prophylaxis against hepatitis B virus recurrence after liver transplantation for hepatitis B virus-related end-stage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy

✍ Yu Zhang; Lunan Yan; Tianfu Wen; Bo Li; Jichun Zhao; Zheyu Chen; Wentao Wang; Mi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 788 KB

Efficacy, safety and pharmacokinetic pro

Efficacy, safety and pharmacokinetic profile of pasteurized intramuscular anti-hepatitis B immunoglobulin for the prophylaxis of hepatitis B virus recurrence after liver transplantation

✍ F. Filipponi; P. Carrai; P. De Simone; A. Franchello; R. Romagnoli; M. Salizzoni 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Low risk of hepatitis B virus recurrence

Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy

✍ Stephen N. Wong; Chi-Jen Chu; Chun-Tao Wai; Terese Howell; Charles Moore; Robert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Hepatitis B virus (HBV) recurrence rates of 0-16% had been reported in patients maintained on nucleoside analogues (NA) after hepatitis B immunoglobulin (HBIG) discontinuation after orthotopic liver transplantation (OLT). However, follow-up in most studies was short. We aimed to determine the long-t

Lamivudine therapy in patients undergoin

Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu

✍ McCaughan, Geoffrey W. ;Spencer, Jenean ;Koorey, David ;Bowden, Scott ;Bartholom 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 75 KB 👁 1 views

Recurrent hepatitis B virus (HBV) infection remains a major cause of morbidity and mortality after liver transplantation. Recently, antiviral therapy, such as lamivudine, has become available for prophylaxis against HBV reactivation posttransplantation and for the treatment of HBV recurrent disease.